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Abstract: Polymeric membranes are employed in guided bone regeneration (GBR) as physical barriers
to facilitate bone in-growth. A bioactive and biomimetic membrane with the ability to participate
in the healing and regeneration of the bone is necessary. The aim of the present study was to
analyze how novel silicon dioxide composite membranes functionalized with zinc or doxycycline can
modulate the osteoblasts’ proliferation, differentiation, and expression of selected antigenic markers
related to immunomodulation. Nanostructured acrylate-based membranes were developed, blended
with silica, and functionalized with zinc or doxycycline. They were subjected to MG63 osteoblast-like
cells culturing. Proliferation was assessed by MTT-assay, differentiation by evaluating the alkaline
phosphatase activity by a spectrophotometric method and antigenic phenotype was assessed by
flow cytometry for selected markers. Mean comparisons were conducted by one-way ANOVA and
Tukey tests (p < 0.05). The blending of silica nanoparticles in the tested non-resorbable polymeric
scaffold improved the proliferation and differentiation of osteoblasts, but doxycycline doped scaffolds
attained the best results. Osteoblasts cultured on doxycycline functionalized membranes presented
higher expression of CD54, CD80, CD86, and HLA-DR, indicating a beneficial immunomodulation
activity. Doxycycline doped membranes may be a potential candidate for use in GBR procedures in
several challenging pathologies, including periodontal disease.
Keywords: CD markers; doxycycline; antigenic phenotype; osteoblasts; membrane
1. Introduction
Guided bone regeneration (GBR) is a frequently used surgical technique. GBR tech-
niques are intended to obtain enough alveolar bone volume to accomplish a successful
therapy with osseointegrated dental implants. In order to achieve this goal, the use of a
membrane, that should not only act as a physical barrier but also as a modulatory barrier,
protecting the growth of osteoblastic cells is required [1]. GBR is a tissue engineering
therapy that greatly relies on the appropriate selection of the biomaterial. Commercially
available membranes can be resorbable or non-resorbable [2]. The shortcoming for re-
sorbable membranes is mainly a lack of space maintenance due to short resorption times.
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On the other hand, for non-resorbable membranes, higher rates of wound dehiscences and
the need for a second surgery in order to retrieve the membrane are the main drawbacks,
as these kinds of membranes do not integrate with the host bone tissue [3].
The search for new osteogenic, bioactive, and biomimetic non-resorbable membranes
that integrate with the bone tissue structure is crucial. The electrospinning technique
can be used for obtaining scaffolds with attractive features, such as the similarity to the
extracellular matrix [4], and may also be successfully used for drug delivery and tissue
regeneration [5,6]. Recently, a new membrane barrier based on the electrospun of a polymer
mixture of (MMA)1-co-(HEMA)1 and (MA)3-co-(HEA)2 has been developed. These nanofi-
brous scaffolds closely mimic the bone collagen matrix (fibers with diameters ranging from
50 to 500 nm) [7]. The composite membranes were formed with silica nanoparticles and
functionalized with zinc or doxycycline. These new composite membranes combine the
mechanical properties of polymeric materials, the bioactivity of SiO2-NPs [7], osteogenicity
provided by the doped zinc [8], and antibacterial properties conferred by the doxycy-
cline [9]. Moreover, zinc has been tested in vivo and in vitro studies, concluding that it
plays a crucial role in inducing the viability and proliferation of bone cells as well as en-
hancing new bone formation and mineralization of extracellular matrix [8,10,11]. Similarly,
doxycycline appears to enhance maturation and cells’ osteogenic capacity [7,12,13].
These novel membranes should also be tested on the cell’s environment. It would be
desirable that the membranes favored osteoblast proliferation and differentiation. It may be
positive that the membranes could contribute to a positive immunomodulation, hindering
the establishment of a pro-inflammatory atmosphere and hampering the penetration of pro-
inflammatory cells and cytokines, thus improving tissue regeneration [14]. A growing body
of evidence has been found about the immunoregulatory potential of biomaterials. It has
been already shown that interactions of osteoblasts with biomaterials can regulate the extent
of the response initiated by macrophages, mainly by osteoblastic release of interleukin-6,
prostaglandin-E2, or granulocyte macrophage colony-stimulating factor [15,16]. The bone
and immune systems are closely related through cellular and molecular interactions [17].
Several regulatory molecules are shared by the immune and skeletal systems, which include
cytokines, receptors, signaling molecules, and transcription factors [17,18].
The cluster of differentiation (CD) is a protocol used for the identification of cells’
surface antigens, providing targets for immunophenotyping of cells. In terms of physiology,
CD molecules can act in numerous ways, often acting as important receptors or ligands to
the cell. The behavior of the cell is usually modified by CD proteins playing a role in cell
signaling or other functions, such as cell adhesion. Assessing CD osteoblasts’ antigenic
phenotype is possible by means of flow cytometry. It is an extremely robust technique
that has been successfully implemented to probe phenotypic cellular activity in living
cells. Namely, the in vitro immunomodulatory properties of bone cells may be ascertained
by determining the deficiency or overexpression of the related CD antigenic markers of
interest at a specific time point of cells’ differentiation stages. It may provide information
about cells’ potential role in immunomodulation [19].
The aim of the present study was to analyze the proliferation, differentiation potential,
and immunomodulation ability of osteoblastic cells cultured on silicon dioxide composite
membranes functionalized with zinc or doxycycline. The null hypothesis is that zinc or
doxycycline addition on membranes does not affect the proliferation, differentiation, and
antigenic phenotype expression of the cultured osteoblasts.
2. Materials and Methods
2.1. Preparation of Nanostructured Polymeric Membranes
Nanostructured membranes were produced by electrospinning using a novel poly-
meric blend: (MMA)1-co-(HEMA)1/(MA)3-co-(HEA)2 50/50 wt.%, doped with 5 wt.%
of SiO2-NPs (NanomyP®, Granada, Spain). The membranes were incubated for 2 h in
a sodium carbonate buffer solution (333 mM; pH = 12.5), so as to activate them with
carboxyl groups (HOOC-Si-M). The partial hydrolysis of ester bonds and the disposal of
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carboxyl groups on the surface of the artificial tissue made this functionalization possi-
ble [20]. The membranes were then rinsed with distilled water and dried using a vacuum
oven [21]. Secondly, the membranes were functionalized with zinc or doxycycline (Dox).
Zinc was incorporated using the ability of carboxyl groups to complex divalent cations.
On the other hand, Dox was immobilized on the membranes by acid–base reactions be-
tween amino groups of Dox and carboxyl groups present in the membranes. HOOC-Si-M
were immersed under continuous shaking at room temperature and in aqueous solutions
(pH = 7) of both 330 mgL−1 of ZnCl2 or 800 mgL−1 of Dox [7]. Four different membranes
were tested: (1) non-functionalized and SiO2-NPs undoped membrane (HOOC-M), (2)
SiO2-NPs doped membrane (HOOC-Si-M), (3) SiO2-NPs doped membrane functionalized
with Zn (Zn-HOOC-Si-M), and (4) SiO2-NPs doped membrane functionalized with Dox
(Dox-HOOC-Si-M). The membranes were placed at the bottom of a 24-well plate (Falcon,
Becton Dickinson Labware, Franklin Lakes, NJ, USA) and sterilized using an ultraviolet
radiation sterilization desk (J.P. SELECTA, Barcelona, Spain).
2.2. Cell Culture
The human MG63 osteosarcoma cell line was purchased from the American Type
Culture Collection (ATCC, Manassas, VA, USA). This cell line has been widely used as an
osteoblast model since it shares most of the same characteristics with primary human os-
teoblasts. MG63 osteoblast-like cells have no interspecies differences with primary human
osteoblasts, they have a shorter isolation time and there is unlimited accessibility [1]. The
MG63 cell line was maintained in Dulbecco’s modified Eagle medium (DMEM; Invitrogen
Gibco Cell Culture Products, Carlsbad, CA, USA) with penicillin 100 IU/mL (Lab Roger SA,
Barcelona, Spain), gentamicin 50 mg/mL (Braum Medical SA, Jaen, Spain), amphotericin B
2.5 mg/mL (Sigma, St. Louis, MO, USA), 1% glutamine (Sigma), and 2% HEPES (Sigma)
supplemented with 10% of fetal bovine serum (FBS; Gibco, Paisley, UK), as described by
Díaz Rodríguez et al. [22]. Cultures were kept in a humidified atmosphere at 37 ◦C of
95% air and 5% CO2. Cells were detached from the flask using 0.05% trypsin (Sigma) and
0.02% ethylenediaminetetraacetic acid (EDTA; Sigma) solution. After this process, they
were rinsed and resuspended in complete culture medium with 10% FBS as described by
Manzano-Moreno et al. [19].
2.3. Cell Proliferation Assay
Osteoblasts were seeded at 1 × 104 cells/mL per well onto the membranes placed
inside the 24-well plate. The cells were then cultured in a humid atmosphere of 95% air
and 5% CO2 at 37 C for 48 h. After this time, cell proliferation was assessed by means of
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) assay. For this purpose,
the media was replaced by phenol red-free DNEM with MTT 0.5 mg/mL (Sigma) and
incubated for 4 h. MTT cellular reduction resulted in the formation of insoluble crystal
deposits of formazan that were dissolved by adding dimethyl sulfoxide (Merck Biosciences,
Darmstadt, Germany). Absorbance was then measured with a spectrophotometer (Sunrise,
Tecan, Männedorf, Switzerland) at 570 nm [23]. The results were expressed as mean
absorbance ± standard deviation (SD). At least three experiments were conducted for each
type of membrane.
2.4. Field Emission Scanning Electron Microscopy (FESEM)
Osteoblasts were also seeded at 1 × 104 cells/mL per well onto the membranes placed
inside the 24-well plate. The cells were then cultured in a humid atmosphere of 95% air
and 5% CO2 at 37 ◦C for 48 h. After this time, two membranes of each experimental group
were submitted to FESEM (GEMINI, Carl Zeiss SMT, Oberkochen, Germany) observation.
Samples were first critical point dried and covered with carbon.
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2.5. Alkaline Phosphatase Activity
Early osteoblasts differentiation was assessed by evaluating the alkaline phosphatase
(ALP) activity, a colorimetric assay (Diagnostic kit 104-LL, Sigma). This method, mea-
sures the conversion of the colorless substrate p-nitrophenyl phosphate to the yellow
p-nitrophenol, accomplished by the ALP enzyme. The rate of color shift corresponded
with the amount of enzyme present in the culture. Standards of p nitrophenol (0–250 µM)
were prepared from dilutions of a 1000 µM stock solution and assayed in parallel. The
ALP assay was performed as previously described by Manzano-Moreno et al. [23]. In brief,
cell cultures, for 72 h on the membranes placed inside the 24-well plate, were trypsinized
(0.05% trypsin, 1 mM EDTA, (Invitrogen Gibco)) and lysed in 100 µL 1 M Tris pH 8.00 by
ultrasonification for 4 min. Then, the suspension was mixed with a 7.6 mM p-nitrophenyl
phosphate solution at a proportion of 1:10 and incubated for 15 min at 37 ◦C. Substrate
solution was prepared by merging an aqueous solution of 4 mg/mL of 4-nitrophenyl
phosphate disodium salt (Sigma) with an equal volume of 1.5 M alkaline buffer (Sigma).
The reaction was stopped by adding 1 mL 0.05 N NaOH, and the final absorbance was
measured with a spectrophotometer (Sunrise, Tecan, Männedorf, Switzerland) at 405 nm.
The total protein content was estimated by the Bradford method using a protein assay kit
from Bio-Rad Laboratories (Bio-Rad Laboratories, Nazareth-Eke, Belgium). All samples
were conducted in triplicate.
2.6. Antigenic Phenotype
Antigenic phenotype was assessed by flow cytometry at 48 h of culture using 0.05%
trypsin (Sigma) and 0.02% EDTA (Sigma) solution 0.4% EDTA solution. They were then
washed and suspended in PBS at a concentration of 2 × 104 cells/mL. Osteoblasts were la-
beled by direct staining with anti-CD54, CD80, CD86, and HLA-DR monoclonal antibodies
(MAbs); CD54/IOL1b, CD80, CD86, and OKDR, respectively (Invitrogen Corp). 100 µL of
cell suspension were incubated with 10 µL of each MAb for 30 min at 4 ◦C in the absence
of light. Cells were rinsed and re-suspended in PBS 1 mL, and analyzed at a wavelength
of 488 nm in a flow cytometer with a diode laser (FACSCanton II, Becton-Dickinson, Palo
Alto, CA, USA) to determine the percentage of fluorescent cells [24].
2.7. Phagocytic Activity
Phagocytic activity was also studied by flow cytometry following the method de-
scribed by Díaz-Rodriguez et al. [25]. In brief, cultured human MG-63 osteosarcoma cells
were cultured for 48 h on the tested membranes. After this time, they were detached from
the membranes, washed, and then suspended in complete culture medium with 10% FBS at
a density of 2 × 104 cells/mL. Cells were treated by direct staining with labeled latex beads;
a 100-µL cell suspension was incubated with 5 µL carboxylated FICT-labeled latex beads
2 µL in diameter (Sigma) for 90 min in darkness at 37 ◦C. Cells were washed, suspended in
1 mL of PBS, and analyzed in a flow cytometer (Facs Vantage; Becton–Dickinson, Palo Alto,
CA, USA). Results were expressed as a percentage of cells positive for phagocytosis and
mean channel fluorescence, which correlates with the number of particles phagocytosed by
the cells. Tests were performed in triplicate and control assays were carried out at 4 ◦C, to
eliminate the background fluorescence. Results were obtained as the percentage of cells
positive for phagocytosis.
2.8. Statistical Analysis
Mean comparisons were conducted by one-way ANOVA and Student–Newman–
Keuls multiple comparisons. Significance was set at p < 0.05. Data were expressed as
means ± standard deviation (SD) in all cases. Before ANOVA, normal distribution was
probed by Kolmogorv–Smirnov tests (p > 0.05).
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3. Results
3.1. Cell Proliferation Assay
Mean and standard deviations of osteoblasts cell proliferation determined by the MTT
assay are presented in Figure 1. Significant differences were found between all tested
groups and attained means follow the trend: COOH-M < HOOC-Si-M < Zn-HOOC-Si-M <
Dox-HOOC-Si-M.
Polymers 2021, 13, x FOR PEER REVIEW 5 of 15 
 
 
2.8. Statistical Analysis  
Mean comparisons were conducted by one-way ANOVA and Student–Newman–
Keuls multiple comparisons. Significance was set at p < 0.05. Data were expressed as 
means ± standard deviation (SD) in all cases. Before ANOVA, normal distribution was 
probed by Kolmogorv–Smirnov tests (p > 0.05). 
3. Results 
3.1. Cell Proliferation Assay  
Mean and standard deviations of osteoblasts cell proliferation determined by the 
MTT ss y are presented n Figure 1. Significant differences were found between all tested 
groups and at ained means follow the tren : COOH-M < HOOC-Si-M < Z -HOOC-Si-M 
< Dox-HOOC-Si-M.  
 
Figure 1. Absorbance mean values and standard deviations obtained after the MTT assay for the different membranes. 
Distinct letter indicates significant difference between membranes after ANOVA and Student–Newman–Keuls multiple 
comparisons (p < 0.05). 
3.2. Field Emission Scanning Electron Microscopy (FESEM)  
Selected images from the FESEM analysis are displayed in Figures 2 and 3. Osteo-
blasts cultured on COOH-Si-M displayed an elongated spindle-shaped morphology and 
a similar situation was observed for those grown on Zn-COOH-Si-M. By contrast, osteo-
blasts on COOH-M are round shaped. For osteoblasts on the Dox-COOH-Si-M the elon-
gated morphology was accompanied by larger and more cytoplasmic membrane protru-
sions compared with those grown on the other membranes. There also exists an alignment 
of the elongated cells on the tested surfaces, which provided large bio-adhesive areas for 
the cells. Cell spreading and cell layer thickness is lower at COOH-M than in the other 
membranes.  
Figure 1. Absorbance mean values and standard deviations obtained after the MTT assay for the different membranes.
Distinct letter indicates significant difference between membranes after ANOVA and Student–Newman–Keuls multiple
comparisons (p < 0.05).
3.2. Field Emission Scanning Electron Microscopy (FESEM)
Selected images from the FESEM analysis are displayed in Figures 2 and 3. Osteoblasts
cultured on COOH-Si-M displayed an elongated spindle-shaped morphology and a simi-
lar situation was observed for those grown on Zn-COOH-Si-M. By contrast, osteoblasts
on COOH-M are round shaped. For osteoblasts on the Dox-COOH-Si-M the elongated
morphology was accompanied by larger and more cytoplasmic membrane protrusions
compared with those grown on the other membranes. There also exists an alignment of the
elongated cells on the tested surfaces, which provided large bio-adhesive areas for the cells.
Cell spreadi an cell layer thickness is lower at COOH-M than in the ther membranes.
3.3. Alkaline Phosphatase (AP) Activity
Mean and standard deviations of alkaline phosphatase expressed as international
units (IU) of AP per mg of total proteins are presented in Figure 4. Significant differences
were found between all tested groups and attained means follow the trend: COOH-M <
HOOC-Si-M < Zn-HOOC-Si-M < Dox-HOOC-Si-M.
3.4. Antigenic Phenotype
The characterization of cultured osteoblasts on the distinct membranes, for the pres-
ence of selected surface markers is presented in Figure 5. Osteoblasts cultured on doxycy-
cline functionalized membranes presented higher expression of CD54, CD80, CD86, and
HLA-DR (p < 0.05), than the rest of the groups. Differences were about (38%, 36%, 53%,
and 64%, respectively). Zinc functionalization reduced CD54 expression on osteoblasts
about 64% (p < 0.001).
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3.5. Phagocytic Activity
Osteoblasts cultured on tested membranes were negative for phagocytosis, except
for those osteoblasts grown on the COOH-M where 24.33% of cells were positive, and the
standard deviation was 1.52%.
4. Discussion
This research manuscript implies an approach to the study of how osteoblasts’ prolif-
eration and differentiation are affected by the different studied nanostructured polymeric
membranes. MG-63 osteoblast-like cells were used for this in vitro study. They are one
of the cell lines most widely used in literature since there are no interspecies differences
with primary human osteoblasts, they have a shorter isolation time and there is unlimited
accessibly [1,26]. However, the results need to be extrapolated with caution, taking into
account that a tumor line may have an alternative pattern of differentiation from primary
human osteoblasts [27,28]. The MTT assay and FESEM were used in order to quantitively
measure osteoblasts’ proliferation while their differentiation potential was evaluated by
means of alkaline phosphatase activity, antigenic phenotype expression, phagocytic activity,
and FESEM.
The previous surface characterization of the present membranes demonstrated that
the mean fiber diameter was of around 765 nm [7]. Taking into account that mineralized
collagen fibrils are about 800 nm in human trabecular bone, these membranes imitate
the osseous structure. This collagen bone mimicking has been shown to increase cell
attachment on membranes by about 1.7 fold [29]. The best strategy when designing an
ideal scaffold is trying to replicate the native tissue and the fibrillar structure, enhancing
cellular attachment, proliferation, and differentiation [1,7].
For topical drug application, the in vitro drug release assay does not correlate with the
expected drug activity. In these cases, product performance tests in similar conditions to the
clinical scenario have been employed. The present methodology involves the determination
of the drug activity on osteoblastic cells, considering the liberated drug and the amount
of drug permeated into the cells. The effect on cells of the quantity of drug which is not
liberated but remained doing its action on the functionalized membrane is also considered.
Moreover, it should also be taken into account that membranes are non-resorbable and do
not swell or dissolve. Therefore, doxycycline and zinc release is controlled by diffusion
of the drug/ions through the liquid permeating the membrane, but as membranes are
bioactive [7], an apatite layer can be formed on the surface, hindering the diffusion of the
drug/ions to the surrounding tissue [30].
Osteoblasts’ proliferation increased on silica-doped membranes, but the best results
were obtained on doxycycline functionalized membranes (Figure 1). It has been previously
reported that tetracyclines promote the proliferation of osteoblasts [4]; but, the underlying
mechanism is not completely understood. Two different events may explain this fact:
(i) osteoblasts’ proliferation is usually enhanced in the presence of antioxidants, as reactive
oxidant species diminish osteoblasts’ reproduction [31], and doxycycline presents a potent
antioxidant effect [32,33]. (ii) Doxycycline possesses calcium chelating ability that may fa-
cilitate calcium deposit on membranes [7]. Increases in extracellular calcium concentration
have been shown to stimulate osteoblastic lineage cells, leading to bone formation and
osteoconductivity [34].
Osteoblasts with an elongated morphology were observed on the doxycycline doped
membranes, with filapodia extensions from the cells to the substrate, producing an in-
terlocked cell structure (Figure 2). This suggests that interplay between the cell and the
membrane surface allows for enhanced dynamic propagation and an overall increase in
osteoblast activation, as indicated by the filopodia. Correlations between cell morphology
and both proliferation and metabolic activity have been previously stated [1,35,36]. Hence,
osteoblast spreading apparently favored the metabolic activity and cell elongation favored
proliferation, while cellular roundness decreased mitotic activity [35,36]. The same corre-
lation was found in the present study, obtaining the highest osteoblasts proliferation for
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the Dox-COOH-Si-M. Rounded and less spread cell shape was found on the COOH-M
(Figure 2), coinciding with a lower cell proliferation. The described correlation of cell
spreading and proliferation has already been reported, not only for osteoblasts but for
other cell types [35]. The cellular morphology seems to be also affected by the presence
of silica, inducing a three-dimensional growth (Figure 3). This three-dimensional cellular
network is the basis for the known in vitro earlier differentiation of osteoblasts and better
osseointegration in vivo [37].
Regarding osteoblasts differentiation, it may be ascertained from phosphatase activity
assays that the silica blending and doxycycline doping of the membranes extremely induces
osteoblasts’ differentiation since it increased the phosphatase activity in about 100% respect
COOM-M (p < 0.001). The AP activity was also enhanced by 50% when osteoblasts were
seeded on Zn-COOH-Si-M when compared with COOH-M (p < 0.001). It could be also
ascertained that regarding AP activity, Dox and Zn could be said to favor osteoblasts’
differentiation, as doping COOH-Si-M with Dox and Zn, raises the AP activity by 70 and
30%, respectively (p < 0.001 in both cases). In previous investigations, the modulation
of genes related to the osteogenic functional capacity of osteoblastic cells exerted by
the studied membranes was evaluated. One of these genes was the one encoding the
alkaline phosphatase, and the same tendency that the observed in the present study was
registered [28].
It was found that osteoblasts expressed major histocompatibility complex molecules
as HLA-DR, and adhesion molecules as CD54, as well as some signaling or co-stimulatory
molecules as CD80 and CD86 [38]. The expression of these molecules is up-regulated by
the tested doxycycline-doped membranes (Figure 5). Expression of HLA-DR, which has
also been described on osteoblasts obtained after mandibular surgery [39], is related to
osteoblasts’ osteocalcin production when stimulated with 1,25-di-hydroxyvitamin D3 [40].
The co-stimulatory molecules CD80 and CD86 are withal expressed by antigen presenting
cells and play pivotal roles in inducing T-cell immunity or tolerance [41,42]. CD80 may
primarily inhibit the immune response, working on T-lymphocytes [43].
The co-stimulatory molecule CD86 is a marker expressed in different cell populations
such as dendritic cells. To understand the meaning of its over-expression it should be taken
into account that the differentiation of osteoclasts is tightly regulated by bone-forming
osteoblasts [44]. Osteoblasts express cytokines essential for osteoclastic differentiation,
like the receptor activator of NF-kB ligand (RANKL) [45,46], in response to osteotropic
hormones and factors [47]. Doxycycline and minocycline have been previously shown to
induce the production of dendritic cell markers, like CD86, in the presence of RANKL [48].
Osteoclast’s precursors express RANK (RANKL receptors) and differentiate into osteoclasts
in response to RANKL emitted by osteoblasts [46,47]. But tetracyclines convert the differ-
entiation pathway, resulting in dendritic-like cells rather than osteoclasts, in the presence
of RANKL in vitro and in vivo [48]. As a result, tetracyclines prevent bone loss [48], but
the mechanism involved is only partially known. Further research is required in this
field. Doxycycline and minocycline inhibited RANKL, which induced osteoclastogenesis,
however, no other clear effect on cell growth and phagocytic activity of osteoclasts has
been described.
Zinc functionalization reduced CD54 expression on osteoblasts and doxycycline pro-
duced its over-expression (Figure 5). CD54 is an adhesion molecule and its presence on
osteoblasts is well documented [39,49]. CD54 upregulation on osteoblastic cells has been
shown to facilitate osteoclastogenesis [50,51]. CD54 is also known as intercellular adhesion
molecule 1, a highly glycosylated immunoglobulin superfamily member that binds the
leukocyte integrins. CD54 is constitutively expressed on leukocytes, epithelial, endothe-
lial, and other cells, and it is up-regulated in response to inflammatory mediators [38,52].
CD54 is the mediating protein involved in the contact between mesenchymal stromal cells
and macrophages. It has an essential role in regulating immunosuppressive properties
of mesenchymal stromal cells [53]. When CD54 is over-expressed by cells, they become
more immunosuppressive in inflammatory environments [54]. There is an unconventional
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but functional CD54-mediated interaction between pro-inflammatory macrophages (M1)
and mesenquimal cells. This crosstalk modulates the immunosuppressive functions of
mesenquimal cells and opens important perspectives in therapies for autoimmune and
inflammatory diseases [53].
Doxycycline has previously been described as a potent anti-inflammatory and antioxi-
dant substance [33]. These properties are related to beneficial doxycycline actions stated
on alveolar tissue inflammatory infiltrates [13]. Oral diseases producing bone loss, such
as periodontitis or periimplantitis, are characterized by inflammation and produce the
activation of immunological cells leading to the release of pro-inflammatory cytokines and
the recruitment of phagocytes and lymphocytes [55].
Phagocytosis is a biological cellular activity through which cells can protect themselves
from infectious and non-infectious environmental particles. The process of phagocytosis
has been previously identified in osteoblasts [25,56] and requires the recognition of ligands
by specific receptors expressed by the phagocyte. Receptor engagement triggers intracel-
lular signaling pathways that initiate appropriate innate immune and pro-inflammatory
responses [57]. Osteoblasts grown on tested functionalized membranes possess a dimin-
ished phagocytic activity, as an additional sign of anti-inflammatory response to tested
doped biomaterials. Just the COOH-M presented about 25% of osteoblasts positive to
phagocytosis activity.
Biomaterial-mediated inflammatory response is crucial for bone regeneration. Exces-
sive inflammation may lead to the formation of fibrous tissue, preventing bone cells from
integrating with the membranes, resulting in the failure of bone regeneration. However,
moderate inflammatory responses may enhance the recruitment and differentiation of
osteoblasts, improving osteogenesis [58]. Further research with macrophages in co-culture
is required determining immunomodulation and osteogenic differentiation.
Despite recent advancements, the therapeutic capability of biomaterials to regulate
the osteoblastic cells-host immune system crosstalk, and the mechanism underlying this
immunoregulation is poorly understood [14]. The most important limitation of the present
study is the lack of mechanistic assays. When the application of detailed mechanistic
assays is being intended [31], it may help to gain insight into a particular mechanism
of action, but it also hinders the multi-regulatory processes that are necessary in the
biological complexity. However, the efficient use of methods, enabling the identification
of cells antigenic phenotype, has an enhanced probability of success in translation of new
biomaterials through to the clinic. It presents a different perspective on signaling focused
on integrated or holistic responses rather than the resolution of individual events. However,
it is recognized that further screening efforts are necessary in order to discover an array
that really allows the study and probing of detailed mechanistic studies, for example how
these receptors are activated/inactivated and then to ascertain the dissection of cellular
pathways. Rather than simplifying, the increasing number of tools should contribute
to refine models and to cover further levels of biological complexity. Analogous to a
puzzle built from multiple individual pieces, the full representation of cellular activity may
transcend following the assembly of different functional outputs.
Since membrane exposure to the oral cavity and contamination of the surgical site are
common problems, the linking of antimicrobial [9], anti-inflammatory, and bone regener-
ation property of doxycycline functionalized membrane makes it a favorable alternative
therapeutic tool for GBR procedures prior to implant placement.
5. Conclusions
In the present study, it has been demonstrated that silica loading may offer beneficial
effects to experimental membranes in terms of osteogenicity (osteoblasts proliferation and
differentiation). Adding zinc to the membranes’ formulation showed an enhancement in
the proliferation capacity of osteoblast. Furthermore, even better results were obtained
when the scaffolds were functionalized with doxycycline. An up-regulation of several
antigenic markers with immune-modulatory potential has also been demonstrated for
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these Dox-COOH-Si-Ms, which may be potential candidates for use in GBR procedures in
several challenging pathologies, including periodontal disease.
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